Biosimilars have potential to offer relief for rising drug plan costs
While the impact of biologics on patients has proven successful, it’s counterbalanced by an equally significant fiscal impact, delegates heard at the 2018 Halifax Benefits…
- By: donalee Moulton
- October 5, 2018 September 13, 2019
- 07:53












